➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
McKinsey
Medtronic
McKesson
Merck

Last Updated: November 30, 2020

DrugPatentWatch Database Preview

Litigation Details for WhatsApp Inc. v. NSO Group Technologies Limited (N.D. Cal. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

WhatsApp Inc. v. NSO Group Technologies Limited (N.D. Cal. 2019)

Docket   Start Trial Date Filed 2019-10-29
Court District Court, N.D. California Date Terminated
Cause 28:1331 Fed. Question Assigned To Phyllis Jean Hamilton
Jury Demand Plaintiff Referred To
Parties FACEBOOK INC.; KING & SPALDING LLP; NSO GROUP TECHNOLOGIES LIMITED; Q CYBER TECHNOLOGIES LIMITED; UNITED STATES DEPARTMENT OF JUSTICE; WHATSAPP INC.
Patents 10,375,955; 10,415,014; 10,443,264; 10,485,796; 10,485,797; 10,485,829; 10,485,851; 10,485,867; 10,633,374; 6,147,103; 6,166,213; 6,191,148; 6,277,584; 6,353,029; 6,369,085; 6,428,810; 6,443,860; 6,461,260; 6,482,584; 6,589,960; 6,699,871; 6,800,309; 6,824,482; 6,867,183; 6,960,938; 6,962,700; 7,009,037; 7,101,847; 7,276,477; 7,411,070; 7,727,571; 7,824,726; 7,824,774; 7,893,324; 7,932,026; 7,938,796; 7,960,371; 8,093,229; 8,287,888; 8,343,955; 8,343,985; 8,461,137; 8,466,305; 8,586,633; 8,591,897; 8,676,324; 8,679,839; 8,709,419; 8,829,862; 8,883,862; 8,962,034; 8,962,860; 8,980,272; 8,980,851; 8,999,289; 9,107,960; 9,119,810; 9,221,867; 9,415,007; 9,415,008; 9,504,660; 9,693,994; 9,713,621; 9,856,510; 9,867,560; 9,926,261; 9,956,465
Attorneys Aaron S Craig; Daniel Joseph Grooms; Elizabeth B Prelogar; Emmet P. Ong; Jessica R. MacGregor; Joseph Douglas Mornin; Joseph N Akrotirianakis; Kyle Christopher Wong; Michael Graham Rhodes; Michael R. Dreeben; Travis LeBlanc
Firms Cooley LLP; King and Spalding LLP; Long & Levit; O'Melveny & Myers LLP; United States Attorney's Office
Link to Docket External link to docket
Small Molecule Drugs cited in WhatsApp Inc. v. NSO Group Technologies Limited

Details for WhatsApp Inc. v. NSO Group Technologies Limited (N.D. Cal. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-03-09 29 Exhibit 3 to Declaration of Joseph D. Mornin quot;the `070 atent") U.S. Patent No. 6,147,103 October• 9, 2018 (&…960 patent, the `424 patent, the `103 patent, the `213 patent, the `148 patent, or the `810 patent -- …230 patent, Che `960 patent, the `424 patent, the `103 patent, the `213 patent, the `1~8 patent, the `810…872 patent; the `810 patent; the `085 patent; and U.S. Patent No. 5,948,789("the `789 patent"…the `960 patent, the `424 patent, the `103 patent, the `213 patent, and the `148 patent. Thus, these External link to document
2020-04-29 59 Motion to Disqualify Defense Counsel Based On Prior Representation in a Sealed Decl. ¶ 6 (ethical wall was not 4 in place as of March 27, 2020); see also Kirk, 183 Cal. App…; Beltran v. 22 Avon Products, Inc., 867 F. Supp. 2d 1068, 1082 (C.D. Cal. 2012) (matters …first arises.” Kirk v. First Am. Title Ins. Co., 183 Cal. App 4th 26 776, 810 (2010) (emphasis… 1242 (N.D. Cal. 1997) (collecting cases in the patent context); see 20 also SC Innovations…Prior Representation in a Sealed Matter - REDACTED, # 6 Declaration of Jacob Sommer iso Motion to Disqualify External link to document
2020-04-30 62 Reply to Opposition/Response Georgalis v. Facebook, Inc., 324 F. Supp. 3d 955 (N.D. Ohio 2018) ................................… Georgalis v. Facebook, Inc., 324 F. Supp. 3d 955, 960 (N.D. Ohio 2018) (rejecting jurisdiction 27 …U.S. at 309–11; Yousuf v. Samatar, 552 F.3d 371, 375–76 (4th Cir. 2009). Derivative sovereign 2 immunity…contract requiring 28 “marketing and sale of . . . patents” in California, “recordkeeping, bookkeeping, accounting…reporting” to California entity, and “payment of patent royalties” to California entity). REPLY External link to document
2020-05-29 79 REDACTED Opposition Telephone: (415) 397-2222 4 Facsimile: (415) 397-6392 … Telephone: (415) 397-2222 4 Facsimile: (415) 397-6392 …................ 8 14 B. CRPC 1.10(b) Permits K&S to Rebut Any Potential…cites to 14 Goldberg, but fails to bring Rule 1.10 to the Court’s attention. Its…They did not: the first involved TWiT’s alleged patent infringement while 17 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Express Scripts
Baxter
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.